본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Cusabio

[CUSABIO] The NECTIN Family 제품 리스트

Cat-No.


CUSABIO는 암, 세포 생물학, 면역학, 신경과학, 후생유전학 등 연구 분야의 글로벌 고객에게 60,000개 이상의 검증된 항체, 

10,000개 이상의 재조합 단백질, 660개 이상의 사이토카인 및 수천 개의 ELISA 키트를 제공하는 검증된 제조업체 입니다. 






NECTIN Family 연구 배경

NECTIN Family는 면역글로불린 초가족(Immunoglobulin Superfamily, IgSF)에 속하는 세포접착분자(Cell Adhesion Molecules, CAMs)로, 세포 간 인식(cell-cell recognition), 세포 접합(junction) 형성, 조직 구조 유지 등 다양한 생리적 과정에서 중요한 역할을 합니다. 고전적인 카드헤린(Cadherin) 계열이 칼슘 이온(Ca²⁺) 의존적으로 세포 간 접합을 형성하는 것과 달리, NECTIN Family는 다양한 동종 결합(homophilic binding)이종 결합(heterophilic binding) 방식을 통해 더욱 복잡한 세포 간 상호작용과 신호 전달을 매개합니다.

연구가 진행됨에 따라 NECTIN Family의 기능은 단순한 세포접착을 넘어 신경계 발달, 바이러스 감염, 면역 조절, 암의 발생 및 진행 등 다양한 생물학적 과정으로 확장되고 있습니다. 각 구성원은 유사한 구조적 특징을 공유하지만, 발현 양상, 결합 파트너, 그리고 하위 신호전달 네트워크의 차이로 인해 생리적·병리적 환경에서 서로 다른 기능을 수행합니다.

따라서 NECTIN Family의 구조적 특성과 기능적 다양성을 체계적으로 이해하는 것은 세포 간 상호작용 메커니즘을 규명하고, 종양면역 연구를 비롯한 다양한 생명과학 연구를 위한 연구 도구 개발 및 새로운 치료 전략 수립에 중요한 기반이 됩니다.


1. Composition and Structural Characteristics of the NECTIN Family

1.1 Classification of NECTIN Family Members

The NECTIN family typically includes two related subgroups: Nectin and Nectin-like (Necl), comprising a total of nine members. The Nectin subgroup includes Nectin-1, Nectin-2, Nectin-3, and Nectin-4; the Necl subgroup includes Necl-1, Necl-2, Necl-3, Necl-4, and Necl-5. Each member has multiple names used across different research fields. The table below summarizes the commonly used aliases (including protein names, former gene symbols, and other database accession numbers) of each member to facilitate literature retrieval.


Family MemberAliases
Nectin-1CD111, HVEC, HLGR, PRR1, PVRL1
Nectin-2CD112, HVEB, PRR2, PVRL2, PVRR2
Nectin-3CD113, PPR3, PRR3, PVRL3, PVRR3
Nectin-4LNIR, PVRL4, PRR4
Necl-1CADM3, SYNCAM3, IGSF4B, TSLL1
Necl-2CADM1, SYNCAM1, IGSF4, IGSF4A, TSLC1
Necl-3CADM2, SYNCAM2, IGSF4D
Necl-4CADM4, SYNCAM4, IGSF4C, TSLL2
Necl-5CD155, HVED, PVR, PVS, TAGE4


From an evolutionary and structural perspective, Nectin and Necl belong to the same related molecular family; however, the two subgroups exhibit significant differences in intracellular structure and signal connection modes, which constitute an important basis for their further functional diversification.

1.2 Common Structural Foundation

All NECTIN family members are single-pass transmembrane proteins whose basic structure consists of an extracellular region, a transmembrane region, and an intracellular region.

Most members possess a typical immunoglobulin-like structure in the extracellular region, usually comprising one IgV domain and two IgC2 domains. This region is responsible for mediating intercellular binding and serves as the primary basis for homophilic and heterophilic interactions within the NECTIN family.

Unlike cadherins, which depend on calcium ions to maintain cell-cell junctions, binding between NECTIN molecules relies primarily on spatial complementarity among immunoglobulin-like domains. Consequently, the NECTIN family can form more flexible recognition patterns between different cell types [1,2].

The intracellular region determines how different members participate in cellular signal regulation. The cytoplasmic tails of classical Nectin members can bind the adaptor protein Afadin, which in turn connects to the actin cytoskeleton, converting adhesion events at the cell surface into cytoskeletal rearrangements and signal responses [2].

In contrast, Necl members generally do not function through the classical Afadin pathway; instead, they participate in cell junctions, migration, and signal regulation through other intracellular binding proteins. This structural difference enables NECTIN family members, despite sharing similar extracellular structures, to engage in distinct biological processes.


2. Molecular Mechanisms of NECTIN Family-Mediated Cell Junctions

2.1 Homophilic and Heterophilic Binding Generate Diverse Cellular Recognition

One of the most important features of the NECTIN family is the ability of its members to form multiple binding modes.

Some members can form stable junctions through homophilic binding, such as mutual recognition between identical molecules. At the same time, heterophilic binding can also occur between different members, for example, the interaction between Nectin-1 and Nectin-3, and the heterodimerization between Necl-4 and Necl-1 [17].

This heterophilic binding capacity distinguishes the NECTIN family from many traditional adhesion molecules. The combination of different NECTIN members expressed on the cell surface can determine whether cell-cell contact occurs and what type of junction is formed, thereby supporting complex cellular arrangement and spatial organization during tissue development.

In the nervous system, precise cell pairing is particularly critical for synapse formation. The heterophilic binding characteristics of NECTIN molecules can help different nerve cells establish selective contacts, providing a molecular foundation for synaptic structure formation [3].

2.2 The Nectin–Afadin System and Junction Formation

One of the most important functions of classical Nectin members is their participation in junction formation through Afadin.

When Nectin molecules on the cell surface bind to each other, their intracellular regions can recruit Afadin. As an important scaffold protein linking membrane proteins and the actin network, Afadin can promote cytoskeletal reorganization and participate in the maturation of adherens junctions.

Studies have found that Nectin-mediated junctions do not exist independently but function in concert with other cell adhesion systems. In epithelial cells, the Nectin–Afadin complex can promote the formation of E-cadherin-mediated adherens junctions and participate in the establishment of tight junctions. Therefore, the NECTIN family plays a "coordinator" role in tissue architecture maintenance rather than simply providing mechanical connections.

2.3 From Cell Adhesion to Signal Regulation

With advancing research, the NECTIN family has been found to influence diverse cellular behaviors, including migration, proliferation, polarity establishment, and cell differentiation.

Cell adhesion itself is also a signaling event. When NECTIN molecules on the cell surface bind to adjacent cells, they can alter cytoskeletal status through intracellular scaffold proteins and signaling molecules, further influencing cell movement and morphological changes.

For example, in addition to participating in cell adhesion, Necl-5/CD155 is also involved in the regulation of cell migration and proliferation. In normal cells, CD155 participates in modulating cell motility; in tumor cells, its aberrant expression may enhance migratory capacity and further influence disease progression [4].


Nectin Family-Mediated Oncogenic Signaling in Tumor Cells and the Tumor Microenvironment

Figure 1. Nectin Family-Mediated Oncogenic Signaling in Tumor Cells and the Tumor Microenvironment [2]

3. Functions of NECTIN Family Members and Disease Research

Although NECTIN family members share similar structural foundations, they exhibit significant differences in tissue expression, binding partners, and biological functions. Among them, Nectin-1, Nectin-2/CD112, Nectin-4, and Necl-5/CD155 are the most intensively studied members, whereas CADM family members are primarily investigated in the context of the nervous system and tumors.

3.1 Nectin-1: A Cell Junction Molecule in Development and a Viral Entry Receptor

Nectin-1 (CD111) is one of the earliest discovered and most thoroughly studied Nectin members, widely expressed in epithelial tissues, the nervous system, and embryo development-related tissues. Its primary function is to participate in tissue architecture formation by mediating intercellular recognition and junctions.

During development, Nectin-1 is involved in cellular arrangement and morphogenesis across multiple tissues. Human genetic studies have found that mutations in the NECTIN1 gene can cause cleft lip/palate-ectodermal dysplasia syndrome (CLPED1), with patients exhibiting phenotypes such as cleft lip/palate, dental anomalies, and ectodermal tissue developmental defects [5]. This finding demonstrates that NECTIN1-mediated cell junctions are not only structurally significant but also indispensable regulatory factors in normal tissue development.

In addition to its role in tissue development, Nectin-1 holds important virological significance. Alphaherpesviruses such as herpes simplex virus type 1/2 (HSV-1/2) and pseudorabies virus (PRV) can exploit Nectin-1 as an important receptor for host cell entry, achieving viral-cell membrane fusion through binding of viral envelope glycoproteins to the Nectin-1 extracellular domain [6]. This discovery has made Nectin-1 an important molecule for studying viral infection mechanisms and host cell recognition.

Thus, Nectin-1 exemplifies a typical characteristic of the NECTIN family: the same cell surface adhesion molecule can participate in normal intercellular communication while also being exploited by pathogens to accomplish infection.

3.2 Nectin-2: A Critical Node Linking Cell Adhesion and Immune Regulation

Nectin-2 (CD112) is currently one of the most immunologically valuable members of the NECTIN family.

Early research primarily focused on the role of CD112 in cell junctions. Subsequent studies revealed that CD112 also serves as a ligand for multiple immune receptors, including CD226 (DNAM-1), TIGIT, and PVRIG, making it an important molecule linking cell surface recognition and immune regulation [7,8].

CD226 is an activating receptor predominantly expressed on natural killer (NK) cells and a subset of T cells. Binding of CD112 to CD226 can promote the recognition and killing of target cells by immune cells. However, CD112 can also bind the inhibitory receptor PVRIG and participate in the inhibition of T cell and NK cell function.

Therefore, CD112 does not possess a simple "activating" or "inhibitory" attribute; rather, it sits within a dynamic regulatory network. Competition among different receptors for CD112 binding can influence the direction of signals ultimately received by immune cells.

In the tumor microenvironment, tumor cells may influence immune cell recognition by altering CD112 expression levels. In recent years, research surrounding the CD112–PVRIG axis has gradually increased, and this pathway is considered a potential novel immune regulatory direction following PD-1/PD-L1 and TIGIT.

3.3 Nectin-3: Involvement in Neural Junctions and Germ Cell Interactions

Compared with Nectin-2 and Nectin-4, Nectin-3 has received less attention in disease research, yet its role in cell recognition within specific tissues is of significant importance.

The most prominent feature of Nectin-3 is its ability to form highly selective heterophilic binding with other Nectin members. For example, the interaction between Nectin-1 and Nectin-3 is believed to participate in cell recognition processes between nerve cells and within synaptic structures.

Cellular junctions in the nervous system are highly specific. Different types of nerve cells need to form stable connections at correct locations, and simple mechanical adhesion cannot meet such refined demands. Nectin-3 provides a molecular recognition mechanism for neural network formation through specific combinations with other members.

In addition, Nectin-3 participates in cell junctions within the reproductive system. Studies have shown that interactions among NECTIN family members are involved in maintaining junctions between Sertoli cells and germ cells during spermatogenesis [9].

At present, Nectin-3 has not yet become a clear drug development target, but it holds significant value for understanding tissue-specific cell recognition mechanisms.

3.4 Nectin-4: From a Development-Related Molecule to a Tumor Therapeutic Target

Nectin-4 (PVRL4) is currently the most clinically successful member of the NECTIN family.

Initially discovered in relation to embryonic tissue development, subsequent studies found that Nectin-4 is aberrantly expressed in a variety of tumor tissues, including urothelial carcinoma, breast cancer, lung cancer, and pancreatic cancer [10].

Compared with normal adult tissues, Nectin-4 expression is markedly elevated in some tumor cells. Additionally, its cell surface localization provides favorable antibody accessibility. These characteristics have made Nectin-4 an important candidate target for antibody drug development.

The most representative application to date is the Nectin-4-targeted antibody-drug conjugate (ADC), Enfortumab vedotin. This drug utilizes an anti-Nectin-4 antibody to recognize Nectin-4 on the tumor cell surface, and upon internalization, releases the cytotoxic payload MMAE, thereby exerting antitumor effects [11].

Clinical studies have demonstrated clear therapeutic efficacy of Enfortumab vedotin in patients with advanced urothelial carcinoma, and it has received regulatory approval for relevant indications [12]. Recently, the FDA further approved its combination with pembrolizumab for perioperative therapy in muscle-invasive bladder cancer (MIBC), regardless of cisplatin eligibility.

The successful validation of Nectin-4 is of great significance: it proves that cell adhesion molecules can serve not only as objects of disease mechanism research but also as direct drug development targets. Current research surrounding Nectin-4 has shifted from "whether it can be targeted" to how to optimize therapeutic outcomes, including expression heterogeneity, resistance mechanisms, and combination therapeutic strategies.

3.5 The CADM Family (Necl-1 to Necl-4): Research on Neural Functions and Tumors

The gene names for Necl-1 to Necl-4 are CADM3, CADM1, CADM2, and CADM4, respectively. It is worth noting that Necl-5 is not classified within the CADM family but is an independent member parallel to classical Nectin molecules. Compared with classical Nectin members, CADM family research is more concentrated in the nervous system and tumor-related fields.

Among them, CADM1 (Necl-2) is one of the most intensively studied members. CADM1 participates in intercellular adhesion and plays a role in synapse formation in the nervous system.

Meanwhile, multiple studies have found that abnormal CADM1 expression is associated with various tumors; particularly in lung cancer, decreased CADM1 expression correlates with reduced cell adhesion capacity and enhanced tumor invasion [13].

CADM2 is predominantly expressed in the nervous system and is believed to participate in information exchange between nerve cells and maintenance of neural functions [14]. CADM3 and CADM4 are also involved in cell junctions within neural tissues and have received attention in some tumor studies.

Overall, CADM members embody the characteristics of NECTIN-like molecules: they do not exist merely as structural adhesion molecules but influence tissue function by regulating intercellular communication. However, compared with Nectin-4 and CD155, the CADM family has not yet established a clear clinical translation direction.

3.6 Necl-5: A Viral Receptor, Cell Migration Regulator, and Core Molecule in Tumor Immunity

Necl-5 (CD155) is one of the most functionally complex members of the NECTIN family.

CD155 was first discovered as the poliovirus receptor. Viruses can exploit CD155 to mediate cell entry, making it a classic subject of virus-host interaction research [15].

Subsequent studies found that CD155 is also involved in normal cell migration, proliferation, and cytoskeletal regulation. During cell migration, CD155 can influence cell movement-related signals, and in various tumors, elevated CD155 expression is associated with enhanced invasiveness [4].

In recent years, the hottest research area for CD155 has been tumor immunity. CD155 can bind multiple immune receptors, including TIGIT, CD226, and CD96. Among these, CD226 generally mediates immune activation, TIGIT has a clearly defined immunosuppressive effect, while CD96 also exerts immunosuppressive functions in most contexts, although its specific mechanisms are still under intensive investigation [16].

Because the same ligand simultaneously participates in both activating and inhibitory signal regulation, CD155 has become a critical balancing node in tumor immunity. When tumor cells highly express CD155, they may enhance inhibitory pathway signals such as TIGIT, restricting immune cell function.

Therefore, Necl-5 (CD155) and Nectin-4 represent two distinct value models of the NECTIN family in the tumor field: Nectin-4 primarily serves as a tumor cell surface antigen for direct drug delivery; whereas CD155 acts as an immune regulatory network node influencing immune cell function, representing an important potential target for tumor immunotherapy.


4. NECTIN Family Research Products

Research on the NECTIN family involves protein-protein interactions, cellular signaling, and disease mechanisms, requiring diverse experimental tools. CUSABIO provides a comprehensive portfolio of research products covering NECTIN family members, applicable to protein-protein interaction analysis, expression detection, receptor binding functional validation, and other scenarios, supporting basic scientific research and drug development.


● Recombinant Protein

TargetCodeProduct NameSource
PVRCSB-CF019093HU(A4)Recombinant Human Poliovirus receptor (PVR)in vitro E.coli expression system
PVRCSB-EP019093HURecombinant Human Poliovirus receptor (PVR), partialE.coli
NECTIN2CSB-EP835690HURecombinant Human Nectin-2 (NECTIN2), partialE.coli
PVRL4CSB-YP822274HURecombinant Human Poliovirus receptor-related protein 4 (NECTIN4), partialYeast
NECTIN2CSB-AP005081HURecombinant Human Nectin-2 (NECTIN2), partial (Active)Mammalian cell
NECTIN4CSB-AP005571HURecombinant Human Nectin-4 (NECTIN4), partial (Active)Mammalian cell
NECTIN4CSB-MP822274HURecombinant Human Nectin-4 (NECTIN4), partial (Active)Mammalian cell
PVRCSB-MP019093HU(M)Recombinant Human Poliovirus receptor (PVR) (I340M), partial (Active)Mammalian cell
PVRCSB-MP019093HUc7Recombinant Human Poliovirus receptor (PVR), partialMammalian cell
Cadm1CSB-MP004425MORecombinant Mouse Cell adhesion molecule 1 (Cadm1), partial (Active)Mammalian cell
CADM1CSB-MP004425HURecombinant Human Cell adhesion molecule 1 (CADM1), partial (Active)Mammalian cell
CADM1CSB-MP004425HUd9Recombinant Human Cell adhesion molecule 1 (CADM1), partialMammalian cell
NECTIN2CSB-MP5776MOVRecombinant Macaca fascicularis Nectin cell adhesion molecule 2 (NECTIN2), partial (Active)Mammalian cell
NECTIN1CSB-MP621867HU-BRecombinant Human Nectin-1(NECTIN1), partial, BiotinylatedMammalian cell
NECTIN2CSB-MP835690HUd7Recombinant Human Nectin-2 (NECTIN2), partialMammalian cell
NECTIN4CSB-EP822274HU-BRecombinant Human Nectin-4 (NECTIN4), partial, BiotinylatedE.coli
NECTIN2CSB-MP835690HURecombinant Human Nectin-2 (NECTIN2), partialMammalian cell


● Antibody

TargetCodeProduct NameTested Applications
PVRCSB-RA567944A0HUPVR Recombinant Monoclonal AntibodyELISA, WB, IHC
NECTIN2CSB-RA835690MA1HUNECTIN2 Recombinant Monoclonal AntibodyELISA
PVRL2CSB-RA582013A0HUPVRL2 Recombinant Monoclonal AntibodyELISA, IHC
CADM2CSB-PA003005CADM2 AntibodyWB, IHC, IF, ELISA
NECTIN3CSB-PA003390PVRL3 AntibodyWB, ELISA
NECTIN3CSB-PA005242PVRL3 AntibodyWB, ELISA
CADM4CSB-PA008004CADM4 AntibodyWB, IHC, IF, ELISA
CADM3CSB-PA040111CADM3 AntibodyWB, IHC, IF, ELISA
NECTIN4CSB-PA060216PVRL4 AntibodyWB, ELISA
CADM1CSB-PA004340CADM1 AntibodyWB, IF, ELISA
NECTIN1CSB-PA006247PVRL1 AntibodyWB, ELISA
NECTIN2CSB-PA006259PVRL2 AntibodyWB, ELISA
PVRCSB-PA006288PVR AntibodyWB, ELISA
CADM1CSB-PA004425GA01HUCADM1 AntibodyELISA, WB
CADM3CSB-PA004427GA01HUCADM3 AntibodyELISA, WB
NECTIN2CSB-PA019096GA01HUPVRL2 AntibodyELISA, WB
NECTIN3CSB-PA019097GA01HUPVRL3 AntibodyELISA, WB, IHC
CADM3CSB-PA130108CADM3 AntibodyELISA, IHC
CADM3CSB-PA195475CADM3 AntibodyELISA, IHC
PVRCSB-PA297000PVR AntibodyELISA, WB, IHC


● ELISA Kit

TargetCodeProduct NameDetection RangeSensitivity
PVRCSB-EL019093HUHuman Poliovirus receptor(PVR) ELISA kitserum, plasma, tissue homogenates7.8 ng/mL-500 ng/mL


References

[1] de Agustín-Durán D,Mateos-White I,Fabra-Beser J, et al. Stick around: Cell-Cell Adhesion Molecules during Neocortical Development. Cells. 2021;10 (1).

[2] Chen R,Chen R,Chen W, et al. Nectins: Orchestrating tumor progression and immune evasion. Crit Rev Oncol Hematol. 2026;217:105058.

[3] Tomorsky J,Parker PRL,Doe CQ, et al. Precise levels of nectin-3 are required for proper synapse formation in postnatal visual cortex. Neural Dev. 2020;15 (1):13.

[4] Paolini R,Molfetta R. CD155 and Its Receptors as Targets for Cancer Therapy. Int J Mol Sci. 2023;24 (16).

[5] Lough KJ,Lough KJ,Spitzer DC, et al. Disruption of the nectin-afadin complex recapitulates features of the human cleft lip/palate syndrome CLPED1. Development. 2020;147 (21).

[6] Sayers CL,Elliott G. Herpes Simplex Virus 1 Enters Human Keratinocytes by a Nectin-1-Dependent, Rapid Plasma Membrane Fusion Pathway That Functions at Low Temperature. J Virol. 2016;90 (22):10379-10389.

[7] Sanchez-Correa B,Valhondo I,Hassouneh F, et al. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy. Cancers (Basel). 2019;11 (6).

[8] Buckle I,Guillerey C. Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer. Cancers (Basel). 2021;13 (17).

[9] Li T,Yao J,Zhang Q, et al. Chronic stress impairs male spermatogenesis function and Nectin-3 protein expression in the testis. Physiol Res. 2020;69 (2):297-306.

[10] Ganguli N,Mukherjee S,Samanta D. Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics. Int J Biol Macromol. 2025;330 (Pt 2):148023.

[11] Shostak Y,Nadell R,Capo L, et al. Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models. Cancer Res. 2016;76 (10):3003-13.

[12] Powles T,Rosenberg JE,Sonpavde GP, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med. 2021;384 (12):1125-1135.

[13] Li H,Gao J,Zhang S. Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer. Front Cell Dev Biol. 2021;9:714298.

[14] Pasman JA,Chen Z,Smit DJA, et al. The CADM2 Gene and Behavior: A Phenome-Wide Scan in UK-Biobank. Behav Genet. 2022;52 (4-5):306-314.

[15] Gao J,Zheng Q,Xin N, et al. CD155, an onco-immunologic molecule in human tumors. Cancer Sci. 2017;108 (10):1934-1938.

[16] Kučan Brlić P,Lenac Roviš T,Cinamon G, et al. Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cell Mol Immunol. 2019;16 (1):40-52.

[17] Liu X,Li D,Li C, et al. Structure of the heterophilic interaction between the nectin-like 4 and nectin-like 1 molecules. Proc Natl Acad Sci U S A. 2019;116 (6):2068-2077.





Cusabio 다른 제품들도 함께 만나보세요!


 

설명: kit

   Kit

 

설명: Protein

   Protein

 

설명: Antibody

   Hot Categories

 

설명: Molecular Biology Product

   Molecular Biology Product

 

설명: Antibody

   Antibody

설명: Small Molecule

   Small Molecule

 

 

CUSABIO - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"